China Covid vaccine indicates rapid immune response within 4 weeks: study

A man works in the laboratory of Chinese vaccine maker Sinovac Biotech, developing an experimental vaccine.

Singapore / Beijing:

Synovac Biotech’s experimental COVID-19 vaccine, CoronaVac, triggered an accelerated immune response, but the level of antibodies produced was lower than those who recovered from the disease, preliminary testing results showed Wednesday.…

This news comes via, which delivers news, data, analysis, and insights on Chinese business, travel, finance, health, military, investment, and technology.

Visit the original:

Comments are closed.